What is Central Regional Pathology Laboratories?
Central Regional Pathology Laboratories operates as an independently owned and managed diagnostic powerhouse, providing essential pathology services to a diverse network of healthcare institutions. With a team of board-certified pathologists, the firm offers deep subspecialty expertise in areas including dermatopathology, breast pathology, and hematopathology. Since relocating to its state-of-the-art laboratory facility in Maplewood, Minnesota, the company has expanded its capacity to serve a growing number of regional clinics and hospitals. Its market position is defined by a service-dedicated approach, bridging the gap between complex laboratory medicine and the immediate needs of physicians and laboratory managers.
How much funding has Central Regional Pathology Laboratories raised?
Central Regional Pathology Laboratories has raised a total of $471K across 2 funding rounds:
Debt
$150K
Debt
$321K
Debt (2020): $150K with participation from PPP
Debt (2021): $321K led by PPP
Key Investors in Central Regional Pathology Laboratories
PPP
Public-Private Partnership
What's next for Central Regional Pathology Laboratories?
With the recent capital deployment, Central Regional Pathology Laboratories is poised to accelerate its strategic initiatives, focusing on the integration of advanced diagnostic technologies and the potential expansion of its subspecialty service offerings. The firm's transition into a larger, more modern facility serves as a foundation for future growth, allowing for increased throughput and the adoption of more sophisticated analytical workflows. As the healthcare landscape in the Midwest continues to evolve, the company is expected to leverage its deep clinical expertise to capture additional market share, potentially exploring new partnerships with regional health systems to further embed its diagnostic infrastructure into the broader medical ecosystem.
See full Central Regional Pathology Laboratories company page
